These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6120945)

  • 1. Renin classification for diuretic and beta-blocker treatment of black hypertensive patients.
    Holland OB; Fairchild C
    J Chronic Dis; 1982; 35(3):179-82. PubMed ID: 6120945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta adrenergic blockers lower renin in patients treated with ACE inhibitors and diuretics.
    Holmer SR; Hense HW; Danser AH; Mayer B; Riegger GA; Schunkert H
    Heart; 1998 Jul; 80(1):45-8. PubMed ID: 9764058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
    Freis ED
    Am Heart J; 1984 Oct; 108(4 Pt 2):1087-91. PubMed ID: 6148868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of renin profile and age in the choice of the therapeutic approach of arterial hypertension (author's transl)].
    Glorioso N; Madeddu P; Dessì Fulgheri P; Sanna G; Fiori C; Dettori S; Cocco F; Rappelli A
    G Ital Cardiol; 1981; 11(12):2117-25. PubMed ID: 6125451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diuretics, beta-blockers or both as treatment for essential hypertension.
    Stumpe KO; Overlack O
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):189S-197S. PubMed ID: 37874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose diuretic and beta adrenoceptor blocker in essential hypertension.
    Weber MA; Priest RT; Ricci BA; Eltorai MI; Brewer DD
    Clin Pharmacol Ther; 1980 Aug; 28(2):149-58. PubMed ID: 6105034
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of renin classification for diuretic treatment of black hypertensive patients.
    Holland OB; Gomez-Sanchez C; Fairchild C; Kaplan NM
    Arch Intern Med; 1979 Dec; 139(12):1365-70. PubMed ID: 518220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of beta-adrenoceptor and calcium-entry blockers in hypertensive blacks.
    M'Buyamba-Kabangu JR; Tambwe M
    Cardiovasc Drugs Ther; 1990 Mar; 4 Suppl 2():389-94. PubMed ID: 1980202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretics and hypertension in black adults.
    Hawkins DW; Dieckmann MR; Horner RD
    Arch Intern Med; 1988 Apr; 148(4):803-5. PubMed ID: 3281620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of plasma renin activity, age, and race in selecting effective initial drug therapy for hypertension.
    Schwartz GL; Bailey K; Chapman AB; Boerwinkle E; Turner ST
    Am J Hypertens; 2013 Aug; 26(8):957-64. PubMed ID: 23591988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating the older hypertensive: beta-blocker or diuretic?
    Ghosh AK
    Curr Med Res Opin; 1985; 9(10):691-6. PubMed ID: 2866932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
    Wright JT; Bakris GL; Bell DS; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Holdbrook FK; Lukas MA; Iyengar M
    J Clin Hypertens (Greenwich); 2007 Nov; 9(11):842-9. PubMed ID: 17978591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-agent and combination therapy of essential hypertension.
    Weber MA; Drayer JI
    Am Heart J; 1984 Aug; 108(2):311-6. PubMed ID: 6147077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The place of the calcium antagonist verapamil in antihypertensive therapy.
    Bühler FR; Hulthén UL; Kiowski W; Müller FB; Bolli P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S350-7. PubMed ID: 6184567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renin-angiotensin-aldosterone system and blood pressure during oxprenolol treatment in hypertensive patients pretreated with diuretics.
    Salvetti A; Pedrinelli R; Simonini N
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):538-42. PubMed ID: 6757151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for angiotensin II receptor blockers in patients with low-renin hypertension.
    Jamerson KA
    Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S24-30. PubMed ID: 10986156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA; Griffin TP; O'Shea PM; Dennedy MC
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confusing messages from the newest of the beta-blocker/diuretic hypertension trials. The Metoprolol Atherosclerosis Prevention in Hypertensives trial.
    Moser M; Sheps S
    Arch Intern Med; 1989 Oct; 149(10):2174-5. PubMed ID: 2572204
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chlorthalidone, oxprenolol, and their combination in hypertensive blacks: a randomized double-blind crossover study.
    Obel AO
    J Cardiovasc Pharmacol; 1989 Mar; 13(3):465-70. PubMed ID: 2471894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.